A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
Clinical trial NCT05890950 · COMPLETED
Trial details
- NCT number
- NCT05890950
- Sponsor
- Kallyope Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2023-07-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.